182 related articles for article (PubMed ID: 9888467)
1. DNA alkylation and interstrand cross-linking by treosulfan.
Hartley JA; O'Hare CC; Baumgart J
Br J Cancer; 1999 Jan; 79(2):264-6. PubMed ID: 9888467
[TBL] [Abstract][Full Text] [Related]
2. Sequence selectivity, cross-linking efficiency and cytotoxicity of DNA-targeted 4-anilinoquinoline aniline mustards.
McClean S; Costelloe C; Denny WA; Searcey M; Wakelin LP
Anticancer Drug Des; 1999 Jun; 14(3):187-204. PubMed ID: 10500495
[TBL] [Abstract][Full Text] [Related]
3. The alkylator treosulfan shows activity towards human renal-cell carcinoma in vivo and in vitro.
Köpf-Maier P
In Vivo; 1998; 12(3):275-88. PubMed ID: 9706471
[TBL] [Abstract][Full Text] [Related]
4. Cross-linking and sequence specific alkylation of DNA by aziridinyl quinones. 2. Structure requirements for sequence selectivity.
Hargreaves RH; Mayalarp SP; Butler J; McAdam SR; O'Hare CC; Hartley JA
J Med Chem; 1997 Jan; 40(3):357-61. PubMed ID: 9022802
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxicity and DNA cross-linking activity of 4-sulfidocyclophosphamides in mouse leukemia cells in vitro.
Erickson LC; Ramonas LM; Zaharko DS; Kohn KW
Cancer Res; 1980 Nov; 40(11):4216-20. PubMed ID: 7471062
[TBL] [Abstract][Full Text] [Related]
6. DNA minor groove targeted alkylating agents based on bisbenzimidazole carriers: synthesis, cytotoxicity and sequence-specificity of DNA alkylation.
Smaill JB; Fan JY; Denny WA
Anticancer Drug Des; 1998 Dec; 13(8):857-80. PubMed ID: 10335264
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of new homochiral bispyrrolidines as potential DNA cross-linking antitumour agents.
Anderson FM; O'Hare CC; Hartley JA; Robins DJ
Anticancer Drug Des; 2000 Apr; 15(2):119-26. PubMed ID: 10901299
[TBL] [Abstract][Full Text] [Related]
8. Role of DNA minor groove alkylation and DNA cross-linking in the cytotoxicity of polybenzamide mustards.
Turner PR; Denny WA; Ferguson LR
Anticancer Drug Des; 2000 Aug; 15(4):245-53. PubMed ID: 11200500
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxicity of treosulfan and busulfan on pediatric tumor cell lines.
Lanvers-Kaminsky C; Bremer A; Dirksen U; Jürgens H; Boos J
Anticancer Drugs; 2006 Jul; 17(6):657-62. PubMed ID: 16917211
[TBL] [Abstract][Full Text] [Related]
10. Kinetics of in Vitro Guanine- N7-Alkylation in Calf Thymus DNA by (2 S,3 S)-1,2-Epoxybutane-3,4-diol 4-methanesulfonate and (2 S,3 S)-1,2:3,4-Diepoxybutane: Revision of the Mechanism of DNA Cross-Linking by the Prodrug Treosulfan.
Romański M; Pogorzelska A; Główka FK
Mol Pharm; 2019 Jun; 16(6):2708-2718. PubMed ID: 31013419
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the mechanism of action of busulfan with hepsulfam, a new antileukemic agent, in the L1210 cell line.
Pacheco DY; Stratton NK; Gibson NW
Cancer Res; 1989 Sep; 49(18):5108-10. PubMed ID: 2766282
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxic effects of treosulfan on prostate cancer cell lines.
Feyerabend S; Feil G; Krug J; Kassen A; Stenzl A
Anticancer Res; 2007; 27(4B):2403-8. PubMed ID: 17695531
[TBL] [Abstract][Full Text] [Related]
13. SJG-136 (NSC 694501), a novel rationally designed DNA minor groove interstrand cross-linking agent with potent and broad spectrum antitumor activity: part 1: cellular pharmacology, in vitro and initial in vivo antitumor activity.
Hartley JA; Spanswick VJ; Brooks N; Clingen PH; McHugh PJ; Hochhauser D; Pedley RB; Kelland LR; Alley MC; Schultz R; Hollingshead MG; Schweikart KM; Tomaszewski JE; Sausville EA; Gregson SJ; Howard PW; Thurston DE
Cancer Res; 2004 Sep; 64(18):6693-9. PubMed ID: 15374986
[TBL] [Abstract][Full Text] [Related]
14. Pre-formulation investigations for establishing a protocol for treosulfan handling and activation.
El-Serafi I; Loy O; Zhao Y; Oerther S; Mattsson J
Pharm Dev Technol; 2019 Jun; 24(5):639-648. PubMed ID: 30474459
[TBL] [Abstract][Full Text] [Related]
15. Gene-specific formation and repair of DNA monoadducts and interstrand cross-links after therapeutic exposure to nitrogen mustards.
Souliotis VL; Dimopoulos MA; Sfikakis PP
Clin Cancer Res; 2003 Oct; 9(12):4465-74. PubMed ID: 14555520
[TBL] [Abstract][Full Text] [Related]
16. Adenine-containing DNA-DNA cross-links of antitumor nitrogen mustards.
Balcome S; Park S; Quirk Dorr DR; Hafner L; Phillips L; Tretyakova N
Chem Res Toxicol; 2004 Jul; 17(7):950-62. PubMed ID: 15257621
[TBL] [Abstract][Full Text] [Related]
17. Chloroacetaldehyde: mode of antitumor action of the ifosfamide metabolite.
Brüggemann SK; Radike K; Braasch K; Hinrichs J; Kisro J; Hagenah W; Peters SO; Wagner T
Cancer Chemother Pharmacol; 2006 Feb; 57(3):349-56. PubMed ID: 16133533
[TBL] [Abstract][Full Text] [Related]
18. Unsymmetrical DNA cross-linking agents: combination of the CBI and PBD pharmacophores.
Tercel M; Stribbling SM; Sheppard H; Siim BG; Wu K; Pullen SM; Botting KJ; Wilson WR; Denny WA
J Med Chem; 2003 May; 46(11):2132-51. PubMed ID: 12747786
[TBL] [Abstract][Full Text] [Related]
19. Toward a myeloablative regimen with clinical potential: II. Treosulfan induces specific skin graft tolerance across haploidentical MHC barriers.
van Pel M; van Breugel DW; Vos W; Ploemacher RE; Boog CJ
Bone Marrow Transplant; 2004 Jan; 33(2):153-9. PubMed ID: 14661037
[TBL] [Abstract][Full Text] [Related]
20. Mitoxantrone and ametantrone induce interstrand cross-links in DNA of tumour cells.
Skladanowski A; Konopa J
Br J Cancer; 2000 Apr; 82(7):1300-4. PubMed ID: 10755405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
